Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: A case-control study

American Heart Journal

Volumn 132, Issue 4, 1996, Pages 790-795

  Bouillanne, Olivier ^a   Millaire, Alain ^a,b   De Groote, Pascal ^a   Puisieux, François ^a   Cesbron, Jean Yves ^a   Jude, Brigitte ^a   Hatron, Pierre Yves ^a   Ducloux, Gérard ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HEART VALVE REPLACEMENT; HIGH RISK PATIENT; HUMAN; LIVEDO RETICULARIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VALVULAR HEART DISEASE;

EID: 0029981083     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90313-0     Document Type: Article

References (30)

1. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924;33:701-37.
2. Leung WH, Wong KL, Lau CP, Wong CK, Liu HW. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990;89:411-9.
3. Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:1541-4.
4. Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies. Circulation 1990;82:369-75.
5. Sturfeld G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus: a study of 75 patients from a defined population. Medicine 1992;71:216-23.
6. Vianna JL, Khamashta MA, Ordi J. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994;96:3-9.
7. Brenner B, Blumenfeld Z, Markiewicz W, Reisner SA. Cardiac involvement in patients with primary antiphospholipid syndrome. J Am Coll Cardiol 1991;18:931-6.
8. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transoesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992;20:1127-34.
9. Galve E, Ordi J, Barquinero J, Evangelista A, Vilardell M, Soler-Soler J. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med 1992;116:293-8.
10. Derumeaux G, Lenormand C, Borg JY, Lévesque H, Tron F, Letac B. Prévalence et description des atteintes cardiaques dans le syndrome primitif des antiphospholipides. Arch Mal Coeur 1992;85:1811-8.
11. Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 1993;125:1123-9.
12. Acar J, Michel PL, Dorent R, Luxereau P, Vahanian A, Cormier B, et al. Evolution des étiologies des valvulopathies opérées en France sur une période de 20 ans. Arch Mal Coeur 1992;85:411-5.
13. Ford SE, Charrette EJP, Knigth J, Pym J, Ford P. A possible role for antiphospholipid antibodies in acquired cardiac valve deformity. J Rheumatol 1990;17:1499-503.
14. Jude B, Goudemand J, Dolle I, Caron C, Watel A, Tiry C, et al. Lupus anticoagulant: a clinical and laboratory study of 100 cases. Clin Lab Haematol 1988;10:41-51.
15. Harris EN, Baguley E, Asherson RA, Hughes GRV. Clinical and serological features of the 'antiphospholipid syndrome' (APS) [abstract]. Br J Rheumatol 1987;26:19.
16. Harris EN, Ghavari AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
17. Harris EN, Gharavi AE, Tincani A. Affinity purified anticardiolipin and anti-DNA antibodies. J Clin Lab Immunol 1985;17:15-62.
18. Triplett DA, Brandt JT, Musgrave KA, Orr CA. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 1988;259:550-4.
19. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989;160:439-43.
20. Outt HJ, de Groot PG, Hasselar P, Van Viet M, Derksen RHWM. Fluctuation of anticardiolipin antibody level in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 1986;1:113-6.
21. Kozlowski CL, Johnson MJ, Gorst DW, Willey RF. Lung cancer, immune thrombocytopenia and the lupus inhibitor. Postgrad Med J 1987;63:793-5.
22. Sehved JF, Dupuy-Fons C, Biron C, Quéré I, Janbon C. A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier Antiphospholipid (MAP) Study. Haemostasis 1994; 24:175-82.
23. Shi W, Krilis SA, Chong BH. Prevalence of lupus anticoagulant in a healthy population: lack of correlation with anticardiolipin antibodies. Aust NZJ Med 1990;20:231-6.
24. Gastineau DA, Kazmier FJ, Nichols WL, Bowie EJW. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol 1985;19:265-75.
25. Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Arch Intern Med 1986;146:2153-6.
26. Hamsten A, Norberg R, Bjorkholm M, De Faire U, Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 1986;1:113-6.
27. Kalunian KC, Peter JB, Middlekauff HR, Sayre J, Ando DG, Mangotich M, et al. Clinical significance of a single test for anticardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 1988;85:602-8.
28. Khamashata MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.
29. Pope JM, Canny CL, Bell DA. Cerebral ischemic events associated with endocarditis, retinal vascular disease and lupus anticoagulant. Am J Med 1991;90:299-309.
30. de Groote P, Tison E, Millaire A, Marquand A, Ducloux G. Les atteintes valvulaires du lupus érythéroateux disséminé: à propos de deux observations [revue de la littérature]. Ann Cardiol Angéiol 1989;38:539-44.